Boot Barn's "Game Changer"; SNAP Shares Recover

EVLO got some analyst love, too

by Josh Selway

Published on Oct 11, 2018 at 1:45 PM

Stocks are trading sharply lower once again, despite this morning's inflation update. However, three names trading higher are retailer Boot Barn Holdings Inc (NYSE:BOOT), social media concern Snap Inc (NYSE:SNAP), and immune system specialist Evelo Biosciences Inc (NASDAQ:EVLO). Here's what's lifting shares of BOOT, SNAP, and EVLO.

Jefferies Chimes in on Boot Barn

BOOT stock is trading up 6.3% at $26.49, after Jefferies waxed optimistic on the company's private brand expansion, calling it a potential "game changer," and raised its earnings-per-share forecast for 2019. The shares are now up roughly 226% over the past 12 months, and hit a two-year high of $31.53 on Sept. 13.

Long call traders have continued to target the retailer, too. For instance, Boot Barn's 10-day call/put volume ratio at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) stands at 20.52. What's more, call open interest is four times that of put open interest among options expiring within three months, according to the security's Schaeffer's put/call open interest ratio (SOIR) of 0.25.

SNAP Recovers Despite Price-Target Cut

SNAP shares earlier hit a fresh all-time low of $6.46, but have since reversed to trade up 2% at $6.72. Goldman Sachs this morning cut its price target to $11 from $17, citing the potential for more headwinds because of slowing user growth -- though the note said a "Twitter-like turnaround" is possible.

Short interest has continued to rise, however, up 12.1% in the last two reporting periods. More than 17% of Snap's float is now in the hands or short sellers, representing four days' worth of buying power, based on the average trading volume.

EVLO Shares Turn Higher

EVLO stock was also the recipient of analyst attention this morning, with Morgan Stanley moving its price target up to $30 from $29. The shares have gained 6.2% as a result to trade at $10.68, though this is still well below $16, where they began trading publicly back on May 9. Yesterday they reached the lowest point on record, bottoming at $10.01.

Most other analysts are very bullish, as well. This is evidenced by the fact that the average 12-month price target is $27.

 

SAGE Therapeutics Stock Hot Ahead of Earnings
The drug name is scheduled to report on Tuesday
Bear Signal Flashing for This Healthcare Stock Before Earnings
At least four analysts have issued price-target cuts on the stock this week
Signal Says This Retail Stock's on Sale
The shares pulled back this week on news of a Levi Strauss IPO
START YOUR DAY SMARTER.

Get Schaeffer's pre-market news bulletin every morning before the bell rings.
It's free to sign up.


Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


How to Predict Volatility Based on Earnings
A free tool can help traders bank big during the upcoming earnings season.
3 of Today's Worst Nasdaq Stocks
The stocks are sitting out today's rally in the broader equities market
2019 Rally Continues for Stock Market
The Nasdaq is eyeing its longest weekly win streak since 2016
How to Predict Volatility Based on Earnings
A free tool can help traders bank big during the upcoming earnings season.